Rocket Lab stock tumbles as first Neutron launch slips to 2027
Rocket Lab (RKLB) shares fell 14% after announcing the first Neutron rocket launch would be delayed to 2027 due to manufacturing issues. CEO Peter Beck cited safety concerns and strong demand. Neutron is key to competing with SpaceX (SPCX) in the medium-lift rocket market. The stock is down 25% this year and 65% from its 52-week high.
How this was made
The 30-second read
Why it matters
The announcement triggered a sharp sell‑off, reflecting investor concerns over execution risk and cash burn, but the company still cites strong demand and a pending Iridium contract.
Market read
The news directly impacts RKLB's share price and may influence sentiment in the broader space launch sector.
What to watch
Strong demand pipeline and upcoming Iridium deal may cushion revenue despite the launch postponement.
Background
Rocket Lab's Neutron program has experienced multiple schedule slips since its 2021 unveiling, with the latest delay pushing the first flight to 2027.
Ticker impact
Rocket Lab announced its first Neutron launch is delayed to 2027, causing the stock to tumble over 14% in early trading.
downward pressure as investors reassess timeline and revenue outlook
A double‑digit same‑day price drop tied to a fresh, material operational setback.
Market effects
Space launch sector may see broader risk aversion as Rocket Lab's delay highlights technical challenges for new medium‑lift rockets.
U.S. small‑cap and aerospace stocks could face short‑term weakness.
Limited to the niche launch market; no immediate global macro effect.
Counterpoint
The delay could allow Rocket Lab to resolve engineering issues, potentially leading to a more reliable vehicle and long‑term upside.
Key entities
- companyRocket Lab
U.S. listed aerospace launch provider (ticker RKLB).
- executivePeter Beck
CEO of Rocket Lab who explained the manufacturing issue.
- companyIridium
Satellite operator in talks for a deal with Rocket Lab.

